These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1461177)

  • 21. Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: expression and re-expression of glycogen phosphorylase.
    Howell JM; Walker KR; Davies L; Dunton E; Everaardt A; Laing N; Karpati G
    Neuromuscul Disord; 2008 Mar; 18(3):248-58. PubMed ID: 18343113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; DiMauro S
    N Engl J Med; 1993 Jul; 329(4):241-5. PubMed ID: 8316268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of deficient muscular glycogenolysis on extramuscular fuel production in exercise.
    Vissing J; Lewis SF; Galbo H; Haller RG
    J Appl Physiol (1985); 1992 May; 72(5):1773-9. PubMed ID: 1601785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease.
    De Stefano N; Argov Z; Matthews PM; Karpati G; Arnold DL
    Muscle Nerve; 1996 Jun; 19(6):764-9. PubMed ID: 8609928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [McArdle's disease: a case report].
    Levy JA; Gagioti SM; Cavalieri MJ; Pereira JR
    Arq Neuropsiquiatr; 1980 Dec; 38(4):411-4. PubMed ID: 6937160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle fatigue in McArdle's disease. Muscle fibre conduction velocity and surface EMG frequency spectrum during ischaemic exercise.
    Linssen WH; Jacobs M; Stegeman DF; Joosten EM; Moleman J
    Brain; 1990 Dec; 113 ( Pt 6)():1779-93. PubMed ID: 2276044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogenosis type V or McArdle's disease.
    Gordon N
    Dev Med Child Neurol; 2003 Sep; 45(9):640-4. PubMed ID: 12948334
    [No Abstract]   [Full Text] [Related]  

  • 28. [McArdle's disease with insulin resistance caused by obesity].
    Maeda N; Kanda F; Nakazawa K; Chihara K
    Rinsho Shinkeigaku; 2002 Jul; 42(7):632-4. PubMed ID: 12661110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
    Mantle D; Lauffart B; Atack J; Lane RJ
    J Neurol Sci; 1987 Mar; 78(1):63-70. PubMed ID: 3471865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,4-Dinitrophenol, muscle biopsy, and McArdle's disease.
    Heller SL; Brooke MH; Kaiser KK; Choski R
    Neurology; 1988 Jan; 38(1):15-9. PubMed ID: 3422109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [McArdle's disease].
    Lavrnić DV; Svetković D; Apostolski S; Rakocević-Stojanović V; Trikić R
    Srp Arh Celok Lek; 1992; 120(7-8):255-8. PubMed ID: 1306014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in arterial K+ and ventilation during exercise in normal subjects and subjects with McArdle's syndrome.
    Paterson DJ; Friedland JS; Bascom DA; Clement ID; Cunningham DA; Painter R; Robbins PA
    J Physiol; 1990 Oct; 429():339-48. PubMed ID: 2277352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
    Vissing J; Haller RG
    N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [McArdle's disease in adults: clinical and genetic study].
    Olmos JM; Zarrabeitia MT; Valero MC; Figols J; Matorras P; Riancho JA
    Med Clin (Barc); 1997 Nov; 109(19):753-5. PubMed ID: 9470186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro.
    Pari G; Crerar MM; Nalbantoglu J; Shoubridge E; Jani A; Tsujino S; Shanske S; DiMauro S; Howell JM; Karpati G
    Neurology; 1999 Oct; 53(6):1352-4. PubMed ID: 10522901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective atrophy of type 1 muscle fibers in McArdle's disease.
    Felice KJ; Grunnet ML; Sima AA
    Neurology; 1996 Aug; 47(2):581-3. PubMed ID: 8757045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. McArdle's disease with late-onset symptoms: case report and review of the literature.
    Felice KJ; Schneebaum AB; Jones HR
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise tolerance and daily life in McArdle's disease.
    Ollivier K; Hogrel JY; Gomez-Merino D; Romero NB; Laforêt P; Eymard B; Portero P
    Muscle Nerve; 2005 May; 31(5):637-41. PubMed ID: 15614801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.
    Paradas C; Fernandez-Cadenas I; Gallardo E; Lligé D; Arenas J; Illa I; Andreu AL
    Neurosci Lett; 2005 Dec; 391(1-2):28-31. PubMed ID: 16154688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. McArdle's disease: a clinical review and case report.
    Keel BR; Brit M
    Tenn Med; 2013; 106(10):33, 37. PubMed ID: 24282836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.